WeSearch

STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

Ed Silverman· ·1 min read · 0 reactions · 0 comments · 15 views
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug

Original article
STAT · Ed Silverman
Read full at STAT →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

Nonprofit buys experimental cancer drug to maintain patient access
STAT·9
Study highlights influence of socioeconomic status on children’s brain development
STAT·7
STAT+: Abridge inks deals with Nvidia and Lilly
STAT·6
STAT+: Novartis doubles down on molecular glue strategy
STAT·8
Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850
STAT·14
Opinion: How long Covid’s scientific stalemate made it politically erasable
STAT·13